Cardiovascular and metabolic effects of a mandibular advancement device and continuous positive airway pressure in moderate obstructive sleep apnea: a …
JAM Uniken Venema, GE Knol-de Vries… - Journal of clinical …, 2022 - jcsm.aasm.org
Study Objectives: It has been suggested that treatment for obstructive sleep apnea (OSA)
reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
Cardiovascular and metabolic effects of a mandibular advancement device and continuous positive airway pressure in moderate obstructive sleep apnea: a …
JAMU Venema, GE Knol-de Vries… - Journal of clinical …, 2022 - research.rug.nl
STUDY OBJECTIVES: It has been suggested that treatment for obstructive sleep apnea
(OSA) reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
(OSA) reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
[HTML][HTML] Cardiovascular and metabolic effects of a mandibular advancement device and continuous positive airway pressure in moderate obstructive sleep apnea: a …
JAMU Venema, GE Knol-de Vries… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Study Objectives: It has been suggested that treatment for obstructive sleep apnea (OSA)
reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
Cardiovascular and metabolic effects of a mandibular advancement device and continuous positive airway pressure in moderate obstructive sleep apnea: a …
UV JAM, GE Knol-de Vries, H van Goor… - Journal of Clinical …, 2022 - europepmc.org
Study objectives It has been suggested that treatment for obstructive sleep apnea (OSA)
reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
Cardiovascular and metabolic effects of a mandibular advancement device and continuous positive airway pressure in moderate obstructive sleep apnea: a …
JAMU Venema, GE Knol-de Vries… - Journal of clinical …, 2022 - research.vu.nl
STUDY OBJECTIVES: It has been suggested that treatment for obstructive sleep apnea
(OSA) reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
(OSA) reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
Cardiovascular and metabolic effects of a mandibular advancement device and continuous positive airway pressure in moderate obstructive sleep apnea: a …
JAMU Venema, GE Knol-de Vries, H van Goor… - 2022 - pubmed.ncbi.nlm.nih.gov
Study objectives It has been suggested that treatment for obstructive sleep apnea (OSA)
reduces cardiovascular risk. So far, knowledge is limited about the difference in the …
reduces cardiovascular risk. So far, knowledge is limited about the difference in the …